Kurume University Medical Center

Sendai 980-8574

0 studies enrolling now · 2 studies all time

What they study most

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Pulmonary Hypertension

Studies at this site

• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early